As with all medications, the cost of imiquimod can vary. Factors that may affect the price you’ll pay include your treatment plan, your insurance coverage, and the pharmacy you use. To find out what ...

Learn everything you need to know about Imiquimod-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Imiquimod is an immune response modifier, prescribed for certain types of skin growths (actinic keratoses) or skin cancer (superficial basal cell carcinoma). The risk or severity of adverse effects ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Five years after treatment, results showed a freedom ...

A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface malignancies in a small case series. The drug appeared fairly safe, although with a ...

Imiquimod 5% cream has shown promise as a treatment for superficial basal cell carcinomas and, in pilot studies, for actinic keratoses (AKs). In this manufacturer-supported, randomized, double-blind, ...

In a randomized trial, recurrence was higher after superficial curettage (SC) plus imiquimod cream than surgical excision (SE) in patients with nodular basal cell carcinoma (nBCC). At 5 years ...

Please provide your email address to receive an email when new articles are posted on . Imiquimod treatment for 16 weeks exhibited a 90% tumor clearance rate in persistent MMIS at margins of resection ...

Alternatives to surgery are needed for the treatment of vulvar intraepithelial neoplasia. We investigated the effectiveness of imiquimod 5% cream, a topical immune-response modulator, for the ...

DNA vaccination against HER-2/neu is an effective way to induce an immune response able to oppose the spontaneous development of mammary tumours occurring in HER-2/neu transgenic mice. In this study, ...

Chemokine receptor CXCR4 mRNA expression may be a marker of the presence of compromised lymph nodes in oral cavity squamous cell carcinoma This is an ASCO Meeting Abstract from the 2005 ASCO Annual ...

A compounded form of imiquimod, a topical immune response-modifying therapy approved for basal cell carcinoma and other conditions, showed promise as a treatment for ocular surface malignancies in a ...